Style | Citing Format |
---|---|
MLA | Kordestani Z, et al.. "Enhanced Beta-Catenin Expression Is Associated With Recurrence of Papillary Thyroid Carcinoma." Endocrine Practice, vol. 24, no. 5, 2018, pp. 411-418. |
APA | Kordestani Z, Sanjari M, Safavi M, Mashrouteh M, Asadikaram G, Abadi MFS, Mirzazadeh A (2018). Enhanced Beta-Catenin Expression Is Associated With Recurrence of Papillary Thyroid Carcinoma. Endocrine Practice, 24(5), 411-418. |
Chicago | Kordestani Z, Sanjari M, Safavi M, Mashrouteh M, Asadikaram G, Abadi MFS, Mirzazadeh A. "Enhanced Beta-Catenin Expression Is Associated With Recurrence of Papillary Thyroid Carcinoma." Endocrine Practice 24, no. 5 (2018): 411-418. |
Harvard | Kordestani Z et al. (2018) 'Enhanced Beta-Catenin Expression Is Associated With Recurrence of Papillary Thyroid Carcinoma', Endocrine Practice, 24(5), pp. 411-418. |
Vancouver | Kordestani Z, Sanjari M, Safavi M, Mashrouteh M, Asadikaram G, Abadi MFS, et al.. Enhanced Beta-Catenin Expression Is Associated With Recurrence of Papillary Thyroid Carcinoma. Endocrine Practice. 2018;24(5):411-418. |
BibTex | @article{ author = {Kordestani Z and Sanjari M and Safavi M and Mashrouteh M and Asadikaram G and Abadi MFS and Mirzazadeh A}, title = {Enhanced Beta-Catenin Expression Is Associated With Recurrence of Papillary Thyroid Carcinoma}, journal = {Endocrine Practice}, volume = {24}, number = {5}, pages = {411-418}, year = {2018} } |
RIS | TY - JOUR AU - Kordestani Z AU - Sanjari M AU - Safavi M AU - Mashrouteh M AU - Asadikaram G AU - Abadi MFS AU - Mirzazadeh A TI - Enhanced Beta-Catenin Expression Is Associated With Recurrence of Papillary Thyroid Carcinoma JO - Endocrine Practice VL - 24 IS - 5 SP - 411 EP - 418 PY - 2018 ER - |